Related references
Note: Only part of the references are listed.Features of extramedullary myeloma relapse: high proliferation, minimal marrow involvement, adverse cytogenetics: a retrospective single-center study of 24 cases
Leo Rasche et al.
ANNALS OF HEMATOLOGY (2012)
Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients
Alessandro Gozzetti et al.
CANCER (2012)
The definition of IgM multiple myeloma
Steven R. Schuster et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Defining IgM multiple myeloma
Roger G. Owen et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach
Joan Blade et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
K. Detweiler Short et al.
LEUKEMIA (2011)
The prognostic significance of cytogenetics and molecular profiling in multiple myeloma
Jeffrey R. Sawyer
CANCER GENETICS (2011)
Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
M. Varettoni et al.
ANNALS OF ONCOLOGY (2010)
Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells
Masaharu Nobuyoshi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma
Lucia Lopez-Anglada et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Expression and prognostic relevance of MAGE-C1/CT7 and MAGE-C2/CT10 in osteolytic lesions of patients with multiple myeloma
Caroline Pabst et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context
Laura Chiecchio et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R. Fonseca et al.
LEUKEMIA (2009)
Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?
E. Katodritou et al.
LEUKEMIA RESEARCH (2009)
Extramedullary relapses after allogeneic non-myeloablative stem cell transplantation in multiple myeloma patients do not negatively affect treatment outcome
M. C. Minnema et al.
BONE MARROW TRANSPLANTATION (2008)
Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics
Karin Bink et al.
HAEMATOLOGICA (2008)
Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma
G. Schilling et al.
LEUKEMIA (2008)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
Herve Avet-Loiseau et al.
BLOOD (2007)
Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma
E Terpos et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis
M Kremer et al.
JOURNAL OF PATHOLOGY (2005)
Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome
R Zeiser et al.
BONE MARROW TRANSPLANTATION (2004)
Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation
N Kröger et al.
BLOOD (2004)
Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions
H Chang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Clinical and biologic implications of recurrent genomic aberrations in myeloma
R Fonseca et al.
BLOOD (2003)
Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation
H Avet-Loiseau et al.
BLOOD (2002)
Multiple myeloma: Evolving genetic events and host interactions
WM Kuehl et al.
NATURE REVIEWS CANCER (2002)
Share Paper
